ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00305708
Brief Title: Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

First Submitted : March 21, 2006
First Submitted that Met QC Criteria : March 21, 2006
First Posted : March 22, 2006 (Estimate)

Last Update Submitted that Met QC Criteria : November 8, 2012
Last Update Posted : November 12, 2012 (Estimate)